Archives
-
o2h Ventures qualified as a finalist as Best EIS Manager – Specialist at Growth Investor Awards 2023
14 August, 2023
-
o2h Ventures selected as finalist for best seed VC in UKBAA awards 2023
14 June, 2023
-
o2h Ventures recognized as a finalist for the EISA Impact Award for 2023
08 June, 2023
-
PharmEnable raises $7.5M in Pre-Series A funding round with a follow-on investment from o2h Ventures
29 May, 2023
-
Is Investing in SEIS ventures risky? – Join the o2h Chaitime Webinar
10 May, 2023
-
Tay Therapeutics, an o2h Ventures portfolio company secures a licensing deal worth over $65 million
05 May, 2023
-
o2h Ventures deals pipeline, Knowledge-intensive EIS Fund closing on 5th April 2023
01 March, 2023
-
Oct 2022, o2h Ventures Fund Newsletter, KI EIS Closing, EISA events
01 November, 2022
-
Aug-Sept 2022, o2h Ventures Fund Newsletter, fifty percent of our companies led by female and more portfolio updates
30 September, 2022
invest in the growth potential of UK life science & AI